IDSA Garners Support for Increased Federal AMR Funding
IDSA members and the Stakeholder Forum on Antimicrobial Resistance (S-FAR), which IDSA convenes, are urging Congress to support increased funding for federal antimicrobial resistance programs in 2021.
As a result of our advocacy, 73 Representatives, led by Rep. Chellie Pingree (D-NH) and Rep. Buddy Carter (R-GA), sent a letter to the House Labor, Health, and Human Services and Appropriations subcommittees calling for increased investment in federal antimicrobial resistance programs. These include the Centers for Disease Control and Prevention, National Institutes of Health, Biomedical Advanced Research and Development Authority, and Strategic National Stockpile.
These investments would support increased antimicrobial stewardship, prevention and surveillance of antimicrobial resistance and research plus development toward new infection-fighting medicines. We will continue to advocate for full funding for AMR programs as the appropriations process moves forward this year.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!